The work of the Tang Prize winners in biopharmaceutical science has revolutionized the genome editing platform, making it programmable like never before, and could help tackle complicated human diseases, both scholars and Tang Prize Selection Committee members said on Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 1.61%
02/05/2025 01:59 PM - Society
Taitung school mourns former Fulbright scholar killed in DC plane crash
02/05/2025 01:37 PM - Society
CDC reports first meningococcal meningitis case of the year
02/05/2025 11:26 AM - Society
Taiwan headline news
02/05/2025 10:35 AM - Business
U.S. dollar lower in Taipei trading
02/05/2025 10:14 AM